logo

For the Inventor, By the Inventor

Rehovot, Israel

Omrix Biopharmaceuticals Inc.


USPTO Granted Patents = 108

% Expired Patents = 18.5



Trademarks = 1

Forward Citations = 490

Loading Chart...
Loading Chart...

71 inventors (with patents filed for the assignee):

goldMedal Israel Nur (55 out of 64 patents)

silverMedal Erez Ilan (31 out of 33 patents)

bronzeMedal Liliana Bar (23 out of 28 patents)

4.  Sivan Doron (17 out of 17 patents)

5.  Roberto Meidler (14 out of 16 patents)

6.  Yair Pilpel (13 out of 13 patents)

7.  Nadav Orr (13 out of 13 patents)

8.  Ronen Eavri (13 out of 14 patents)

9.  Ashley DeAnglis (12 out of 20 patents)

10.  Moti Meron (12 out of 13 patents)

11.  Yuri Zherdev (11 out of 11 patents)

12.  Omri Faingold (11 out of 12 patents)

13.  Dwayne Lee Looney (10 out of 30 patents)

14.  Yotam Gurman (9 out of 10 patents)

15.  Oleg Belyaev (9 out of 9 patents)


Core Competencies:
Thrombin
Hemostatic Composition
Antimicrobial
Fibrin Sealant
Protein Assay
Viral Inactivation
Wound Dressing
Sample Preparation
Fluid Composition
Syringe Assembly
Gelatin Sponge
Reinforced Dressing

108 patents:

1. 12351843 - Method for purifying and quantifying thrombin and its degradation polypeptides (2025-07-08),
2. 12311015 - Stable liquid thrombin compositions (2025-05-27),
3. 12203947 - Device and process for sample preparation (2025-01-21),
4. 12133868 - Viral inactivated biological mixture (2024-11-05),
5. 12082796 - Device and method for the application of a curable fluid composition to a bodily organ (2024-09-10),
6. 11993797 - Thrombin solution and methods of use thereof (2024-05-28),
7. 11986489 - Method of treating a disease using a glycolytic dependent compound (2024-05-21),
8. 11957798 - Wound dressing and a method for producing the same (2024-04-16),
9. 11957324 - Device and method for preparing and administering one-component fibrin sealant (2024-04-16),
10. 11938165 - Stable pharmaceutical foam (2024-03-26),
11. 11918629 - Low concentrated protein compositions for preventing tissue adhesion (2024-03-05),
12. 11911448 - Stable liquid thrombin compositions (2024-02-27),
13. 11857564 - Hemostatic composition comprising an anion exchanger and a calcium salt (2024-01-02),
14. 11712495 - Hemostatic mixture of cellulose-based short and long fibers (2023-08-01),
15. 11697006 - Powder dispensing applicator (2023-07-11),
Company Overview
Omrix Biopharmaceuticals Inc., based in Rehovot, Israel, specializes in the development and manufacturing of innovative thrombin compositions and hemostatic solutions. The company focuses on advanced technologies in areas such as antimicrobial agents, fibrin sealants, and viral inactivation, which are essential for effective wound management and surgical applications. Their expertise extends to protein assays and sample preparation, positioning them as a key player in the biopharmaceutical sector dedicated to enhancing patient care through cutting-edge solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

108 Patents

#7 in Rehovot

#56 in Israel

#7,275 in the World

Rehovot, IL
Rehovot, Israel

Omrix Biopharmaceuticals Inc.

Forward Citations = 490

71 inventors:

goldMedal Israel Nur (55 out of 64 patents)

silverMedal Erez Ilan (31 out of 33 patents)

bronzeMedal Liliana Bar (23 out of 28 patents)

4.  Sivan Doron (17 out of 17 patents)

5.  Roberto Meidler (14 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Omrix Biopharmaceuticals Inc.. Retrieved from https://idiyas.com/company/omrix-biopharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…